Farther Finance Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14K | Sell |
66
-439
| -87% | -$7.6K | ﹤0.01% | 3863 |
|
|
2025
Q1 | $11.5K | Buy |
505
+329
| +187% | +$7.46K | ﹤0.01% | 2677 |
|
|
2024
Q4 | $5.62K | Buy |
176
+136
| +340% | +$4.34K | ﹤0.01% | 2618 |
|
|
2024
Q3 | $1.16K | Sell |
40
-42
| -51% | -$1.22K | ﹤0.01% | 3190 |
|
|
2024
Q2 | $2.98K | Sell |
82
-6
| -7% | -$218 | ﹤0.01% | 2624 |
|
|
2024
Q1 | $5.25K | Buy |
88
+1
| +1% | +$60 | ﹤0.01% | 2043 |
|
|
2023
Q4 | $5.21K | Buy |
87
+31
| +55% | +$1.86K | ﹤0.01% | 1948 |
|
|
2023
Q3 | $2.13K | Buy |
56
+43
| +331% | +$1.64K | ﹤0.01% | 1836 |
|
|
2023
Q2 | $1.18K | Hold |
13
| – | – | ﹤0.01% | 1921 |
|
|
2023
Q1 | $857 | Hold |
13
| – | – | ﹤0.01% | 1885 |
|
|
2022
Q4 | $672 | Buy |
+13
| New | +$672 | ﹤0.01% | 1757 |
|